Correction to Shire's ViroPharma Buy Story
11 November 2013 - 9:20PM
Dow Jones News
"Shire Buys Rare Disease Firm ViroPharma for $4.2B >SHP.LN,"
at 0736 GMT, incorrectly described Shire as a U.K. specialty
biopharmaceutical company in the first paragraph. It is a worldwide
company listed on the LSE and NASDAQ, and has its corporate
headquarters in Dublin, Ireland.
Viropharma Incorporated (MM) (NASDAQ:VPHM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Viropharma Incorporated (MM) (NASDAQ:VPHM)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Viropharma Incorporated (MM) (NASDAQ): 0 recent articles
More ViroPharma Inc. News Articles